Media Pack
News

Current Edition

Volume 16 Issue 3
 
 
Volume 14 Issue 3

An Alternative Approach to Continued COVID-19 Research

COVID-19 has dominated our lives for two years now. Although we are returning to a new normal, with the help of rapidly developed vaccines, do we truly understand the...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Broadening the Treatment Horizon for Heart Failure Patients

Through its issuance of recommendations and regulatory decisions concerning medical products, the US Food and Drug Administration (FDA) typically considers the “unmet...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Rapid Rise of Decentralised Clinical Trials

As the world continues to adapt to the impact of the pandemic, a legacy has seen the evolvement of varying approaches to how clinical trials are designed and deployed...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

International Clinical Trials Day – R&D Experts Weigh in on What the Future Holds

Each year, on the 20th of May, the global health community celebrates International Clinical Trials Day, the anniversary of James Lind’s famous scurvy experiment in 1...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Calculating Sample Size for Medical Device Studies

Sample size has always been one of the first design choices a medical device sponsor has to make for a clinical study. But the calculation of sample size is not the m...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Get your Ducks in a Row for the Data-driven Future

Stakeholders across the life sciences industry now understand that data is more important than documents but also that it’s crucial that the data is reliable and can ...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

The Relevance of the Guidelines on Good Distribution Practice (GDP) in the World of International Clinical Trials

The successful execution of international clinical trials requires the involvement of service providers adhering to a wide range of regulatory guidelines and industry...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Regenerative Medicine: Confusion or Complacency?

The subject of Regenerative Medicine is currently at an inflexion point. There has been an enormous amount of financial investment, along with basic and clinical rese...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Challenges of Drug Development in Drug Resistant Focal Epilepsy

Epilepsy is one of the most common and disabling chronic neurologic disorders that affects more than 50 million people worldwide. Despite the current of over two doze...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Volume 14 Issue 3

Transcriptome Analysis of Acute Myeloid Leukaemia Cells

Acute Myeloid Leukaemia (AML) is a blood cancer characterised by the overproduction of immature white blood cells in the bone marrow. These proliferating immature cel...
21 June 2022 Volume 14 Issue 3
Continue Reading →
 
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte